DUVYZAT Trademark

Trademark Overview


On Monday, March 18, 2024, a trademark application was filed for DUVYZAT with the United States Patent and Trademark Office. The USPTO has given the DUVYZAT trademark a serial number of 98454709. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 10, 2024. This trademark is owned by ITALFARMACO S.P.A.. The DUVYZAT trademark is filed in the Pharmaceutical Products category with the following description:

Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
duvyzat

General Information


Serial Number98454709
Word MarkDUVYZAT
Filing DateMonday, March 18, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Description of MarkThe mark consists of a set of colored boxes and one circle ranging in color from blue to purple to green, and in size from large to small starting on the right side and arching over the letters "DUV" in the stylized word element "DUVYZAT" in blue, with the final design element being a green circle above the letter "V".
Goods and ServicesBiochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
Indication of Colors claimedThe colos blue, purple, and green are claimed as a feature of the mark.
Translation of Words in MarkThe wording "DUVYZAT" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameITALFARMACO S.P.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMilano 20126
IT

Trademark Events


Event DateEvent Description
Monday, March 18, 2024NEW APPLICATION ENTERED
Monday, August 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 21, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, September 26, 2024ASSIGNED TO EXAMINER
Thursday, September 26, 2024NON-FINAL ACTION E-MAILED
Wednesday, October 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN
Thursday, September 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED